SCYNEXIS, INC. SERIES C-2 PREFERRED STOCK PURCHASE AGREEMENTSeries C-2 Preferred Stock Purchase Agreement • March 19th, 2014 • Scynexis Inc • Pharmaceutical preparations • New York
This SERIES C-2 PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of March 11, 2008, by and among Scynexis, Inc., a Delaware corporation formerly known as ScyRex, Inc. and as SCYNEXIS Chemistry & Automation, Inc. (“SCYNEXIS” or the “Company”), Merial Limited, a company limited by shares registered in England and Wales (registered number 3332751) with a registered office at PO Box 327, Sandringham House, Sandringham Avenue, Harlow Business Park, Harlow, Essex CM19 5TG, England, and domesticated in Delaware, USA as Merial LLC (“Merial”) and S.R. One, Limited (“SR One” and, together with Merial, the “Investors”).
SERIES C-2 PREFERRED STOCK PURCHASE AGREEMENT DATED AS OF SEPTEMBER 2, 2004 BETWEEN NANOSPHERE, INC. AND THE PERSONS LISTED ON THE SCHEDULE OF PURCHASERS ATTACHED HERETOSeries C-2 Preferred Stock Purchase Agreement • September 27th, 2007 • Nanosphere Inc • Surgical & medical instruments & apparatus • Delaware
THIS SERIES C-2 PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of September 2, 2004 between Nanosphere, Inc., a Delaware corporation (together with its predecessor, Nanosphere, LLC, an Illinois limited liability company, the “Company”), and the Persons listed on the Schedule of Purchasers attached hereto (collectively referred to herein as the “Purchasers” and individually as a “Purchaser”). Except as otherwise indicated herein, capitalized terms used herein are defined in Section 6 hereof.
